| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Senti Biosciences, Inc. | CEO and Interim PFO and PAO, Director | Common Stock | 724,440 | $1,629,990 | $2.25 | 07 Mar 2025 | Direct |
| Senti Biosciences, Inc. | CEO and Interim PFO and PAO, Director | Common Stock | 52,839 | $118,888 | $2.25 | 06 Mar 2025 | By spouse |
| Senti Biosciences, Inc. | CEO and Interim PFO and PAO, Director | Common Stock | 52,839 | $118,888 | $2.25 | 06 Mar 2025 | Indirect |
| Senti Biosciences, Inc. | CEO and Interim PFO and PAO, Director | Stock Option (Right to Buy) | 1,927,073 | 06 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SNTI | Senti Biosciences, Inc. | 06 Mar 2025 | 2 | $0 | 4 | CEO and Interim PFO and PAO, Director | 10 Mar 2025, 19:01 |
| SNTI | Senti Biosciences, Inc. | 04 Feb 2025 | 2 | -$18,339 | 4 | CEO, Director | 06 Feb 2025, 20:23 |
| SNTI | Senti Biosciences, Inc. | 01 Feb 2024 | 2 | $0 | 4 | CEO and President, Director | 02 Feb 2024, 17:27 |
| SNTI | Senti Biosciences, Inc. | 01 Feb 2023 | 1 | $0 | 4 | CEO and President, Director | 02 Feb 2023, 16:20 |
| SNTI | Senti Biosciences, Inc.\ | 08 Jun 2022 | 0 | $0 | 3 | CEO and President, Director | 15 Jun 2022, 18:00 |